147 related articles for article (PubMed ID: 27900988)
1. Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era.
Wang Q; Qin Y; Kang SY; He XH; Liu P; Yang S; Zhou SY; Zhang CG; Gui L; Yang JL; Sun Y; Shi YK
Chin Med J (Engl); 2016 Dec; 129(23):2780-2785. PubMed ID: 27900988
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era.
Wang Q; Qin Y; Zhou S; He X; Yang J; Kang S; Liu P; Yang S; Zhang C; Gui L; Sun Y; Shi Y
Oncotarget; 2016 Nov; 7(44):72219-72228. PubMed ID: 27750215
[TBL] [Abstract][Full Text] [Related]
3. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Diefenbach CS; Li H; Hong F; Gordon LI; Fisher RI; Bartlett NL; Crump M; Gascoyne RD; Wagner H; Stiff PJ; Cheson BD; Stewart DA; Kahl BS; Friedberg JW; Blum KA; Habermann TM; Tuscano JM; Hoppe RT; Horning SJ; Advani RH
Br J Haematol; 2015 Nov; 171(4):530-8. PubMed ID: 26343802
[TBL] [Abstract][Full Text] [Related]
5. International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.
Moccia AA; Donaldson J; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Shenkier TN; Slack GW; Skinnider B; Gascoyne RD; Connors JM; Sehn LH
J Clin Oncol; 2012 Sep; 30(27):3383-8. PubMed ID: 22869887
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Utility of the IPS 3 Score for Predicting Outcomes in Advanced Hodgkin Lymphoma.
Ganesan P; Dhanushkodi M; Ganesan TS; Radhakrishnan V; Kannan K; Sundersingh S; Sagar TG
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):116-122. PubMed ID: 30579722
[TBL] [Abstract][Full Text] [Related]
7. Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.
Guisado-Vasco P; Arranz-Saez R; Canales M; Cánovas A; Garcia-Laraña J; García-Sanz R; Lopez A; López JL; Llanos M; Moraleda JM; Rodriguez J; Rayón C; Sabin P; Salar A; Marín-Niebla A; Morente M; Sánchez-Godoy P; Tomás JF; Muriel A; Abraira V; Piris MA; Garcia JF; Montalban C;
Leuk Lymphoma; 2012 May; 53(5):812-9. PubMed ID: 22185637
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
9. [Survival and prognosis analysis of patients with Hodgkin lymphoma treated with standard treatment paradigm].
Shi YK; Tao XH; He Y; Qin P; Liu ST; Zhou JL; Yang LJ; Zhou YW; Song SL; Wang J; Jin H; Fang YP; Liu Y; Zhang SN; Qi Y; Yang CG; Zhang C; Yang L; Gui L
Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(41):3295-3303. PubMed ID: 36319182
[No Abstract] [Full Text] [Related]
10. Low platelet/platelet distribution width and high platelet/lymphocyte ratio are adverse prognostic factors in patients with newly diagnosed advanced Hodgkin lymphoma.
Tao Y; He X; Qin Y; Liu P; Zhou S; Yang J; Zhou L; Zhang C; Yang S; Gui L; Shi Y
Leuk Lymphoma; 2021 Dec; 62(13):3119-3129. PubMed ID: 34296652
[TBL] [Abstract][Full Text] [Related]
11. A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma.
Tao Y; Chen H; Zhou Y; He X; Qin Y; Liu P; Zhou S; Yang J; Zhou L; Zhang C; Yang S; Gui L; Shi Y
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e486-e494. PubMed ID: 35238169
[TBL] [Abstract][Full Text] [Related]
12. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
Montoto S; Shaw K; Okosun J; Gandhi S; Fields P; Wilson A; Shanyinde M; Cwynarski K; Marcus R; de Vos J; Young AM; Tenant-Flowers M; Orkin C; Johnson M; Chilton D; Gribben JG; Bower M
J Clin Oncol; 2012 Nov; 30(33):4111-6. PubMed ID: 23045581
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognostic factors in Chinese patients with classical Hodgkin's lymphoma involving extranodal sites: a retrospective single-center.
Zou DM; Zhou DB; Zhang Y; Wang W; Zhang W
Hematology; 2019 Dec; 24(1):661-668. PubMed ID: 31537183
[No Abstract] [Full Text] [Related]
14. Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? German Hodgkin Lymphoma Study Group.
Franklin J; Paulus U; Lieberz D; Breuer K; Tesch H; Diehl V
Ann Oncol; 2000 May; 11(5):617-23. PubMed ID: 10907959
[TBL] [Abstract][Full Text] [Related]
15. Treatment results in advanced stage Hodgkin's lymphoma: a retrospective study.
Jain H; Sengar M; Nair R; Menon H; Laskar S; Shet T; Gujral S; Sridhar E
J Postgrad Med; 2015; 61(2):88-91. PubMed ID: 25766339
[TBL] [Abstract][Full Text] [Related]
16. 25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma.
Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W
Leuk Res; 2021 Jun; 105():106580. PubMed ID: 33836479
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
[TBL] [Abstract][Full Text] [Related]
18. The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.
Rodday AM; Parsons SK; Upshaw JN; Friedberg JW; Gallamini A; Hawkes E; Hodgson D; Johnson P; Link BK; Mou E; Savage KJ; Zinzani PL; Maurer M; Evens AM
J Clin Oncol; 2023 Apr; 41(11):2076-2086. PubMed ID: 36495588
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
Zanotti R; Trolese A; Ambrosetti A; Nadali G; Visco C; Ricetti MM; Benedetti F; Pizzolo G
Ann Oncol; 2002 Dec; 13(12):1908-14. PubMed ID: 12453859
[TBL] [Abstract][Full Text] [Related]
20. Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma.
Hayden AR; Lee DG; Villa D; Gerrie AS; Scott DW; Slack GW; Sehn LH; Connors JM; Savage KJ
Br J Haematol; 2020 Apr; 189(1):122-127. PubMed ID: 31822034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
